Acetylcholine–dopamine interactions in the pathophysiology and treatment of CNS disorders

DB Lester, TD Rogers, CD Blaha - CNS neuroscience & …, 2010 - Wiley Online Library
Dopaminergic neurons in the substantia nigra pars compacta and ventral tegmental area of
the midbrain form the nigrostriatal and mesocorticolimbic dopaminergic pathways that …

[HTML][HTML] Dihydroisotanshinone I and BMAL-SIRT1 pathway in an in vitro 6-OHDA-induced model of Parkinson's disease

HC Su, YT Sun, MY Yang, CY Wu, CM Hsu - International journal of …, 2023 - mdpi.com
Danshen has been widely used for the treatment of central nervous system diseases. We
investigated the effect of dihydroisotanshinone I (DT), a compound extracted from Danshen …

Dopamine: agonists and neurodegenerative disorders

S Khanam, YH Siddique - Current drug targets, 2018 - ingentaconnect.com
Background: Parkinson's disease (PD) is a neurodegenerative disease characterized by the
loss of dopaminergic neurons within the substantia nigra pars compacta (SNpc). Despite …

[HTML][HTML] Balancing contested meanings of creativity and pathology in Parkinson's Disease

D Porter - Balancing the self, 2020 - manchesterhive.com
Parkinson's Disease is one of the defining degenerative diseases of ageing populations. In
2005 there were an estimated 4.1 million sufferers worldwide, a figure projected to reach 8.7 …

Non-human primate models for Parkinson's disease

IH Philippens - Drug Discovery Today: Disease Models, 2008 - Elsevier
The increasing prevalence of neurodegenerative diseases, like Parkinson's disease, is an
increasing concern for the ageing western societies. As the current medications cannot cure …

[HTML][HTML] Synergistic effect of bromocriptine and tumor necrosis factor-α on reversing hepatocellular carcinoma multidrug resistance in nude mouse MDR1 model of …

L Ding, XP Chen, ZW Zhang, J Guan… - World Journal of …, 2005 - ncbi.nlm.nih.gov
AIM: To investigate the effect of bromocriptine (BCT) and tumor necrosis factor-α (TNF-α) on
hepatocellular carcinoma (HCC) multidrug resistance (MDR) in nude mouse MDR model of …

Clinical efficacy of bromocriptine and the influence of serum prolactin levels on disease severity in patients with chronic plaque-type psoriasis

NA AbouKhedr, AA Eid - Alexandria Journal of Medicine, 2013 - ajol.info
Background: Psoriasis is a T-cell mediated hyperproliferative cutaneous disease of
multifactorial etiology. Prolactin (PRL) has been implicated in the pathogenesis of psoriasis …

Effects of rotigotine transdermal system on non-motor symptoms in Parkinson's disease: an overview

TA Zesiewicz, P Martinez-Martin - Expert Review of …, 2013 - Taylor & Francis
Parkinson's disease (PD) is a progressive neurodegenerative disease, involving the
dopaminergic, noradrenergic, serotonergic and cholinergic systems. In addition to its …

Effect of Cabergoline on Cognitive Impairments in Transgenic Drosophila Model of Parkinson's Disease

YH Siddique, M Idrisi, M Shahid - Letters in Drug Design & …, 2020 - ingentaconnect.com
Background: Parkinson's disease is a common neurodegenerative disorder characterized
by selective loss of dopaminergic neurons in the substantia nigra pars compacta …

[HTML][HTML] Consenso Nacional de Expertos: recomendaciones para el manejo del paciente con enfermedad de Parkinson

R Avello, O Benavides, P Chana-Cuevas… - Revista chilena de …, 2012 - SciELO Chile
Consenso Nacional de Expertos: recomendaciones para el manejo del paciente con
enfermedad de Parkinson SciELO - Scientific Electronic Library Online vol.50 número4 …